These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 33984154)

  • 1. Pregnancy outcomes in women with booking HbA1c ≤ 40 mmol/mol compared with 41-49 mmol/mol in South Auckland, New Zealand.
    Lim Y; Coomarasamy C; Arrol S; Oyston C; Okesene-Gafa K; McCowan LME
    Aust N Z J Obstet Gynaecol; 2021 Oct; 61(5):742-749. PubMed ID: 33984154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Women with an HbA1c of 41-49 mmol/mol (5.9-6.6%): a higher risk subgroup that may benefit from early pregnancy intervention.
    Rowan JA; Budden A; Ivanova V; Hughes RC; Sadler LC
    Diabet Med; 2016 Jan; 33(1):25-31. PubMed ID: 26031320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potentially modifiable predictors of adverse neonatal and maternal outcomes in pregnancies with gestational diabetes mellitus: can they help for future risk stratification and risk-adapted patient care?
    Antoniou MC; Gilbert L; Gross J; Rossel JB; Fischer Fumeaux CJ; Vial Y; Puder JJ
    BMC Pregnancy Childbirth; 2019 Dec; 19(1):469. PubMed ID: 31801465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Despite treatment, HbA1c ≥ 37 mmol/mol in the first trimester is associated with premature delivery among South Asian women with gestational diabetes mellitus: a retrospective cohort study.
    Punnose J; Malhotra RK; Sukhija K; Rijhwani RM; Choudhary N; Sharma A
    Arch Gynecol Obstet; 2024 Aug; 310(2):863-872. PubMed ID: 38517506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early diabetes treatment is associated with improved outcomes in pregnant women with a first antenatal HbA1c of 41-46 mmol/mol.
    Rowan JA; Sadler L
    Aust N Z J Obstet Gynaecol; 2022 Jun; 62(3):395-400. PubMed ID: 35025107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An early pregnancy HbA1c ≥5.9% (41 mmol/mol) is optimal for detecting diabetes and identifies women at increased risk of adverse pregnancy outcomes.
    Hughes RC; Moore MP; Gullam JE; Mohamed K; Rowan J
    Diabetes Care; 2014 Nov; 37(11):2953-9. PubMed ID: 25190675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Baseline HbA1c to Identify High-Risk Gestational Diabetes: Utility in Early vs Standard Gestational Diabetes.
    Sweeting AN; Ross GP; Hyett J; Molyneaux L; Tan K; Constantino M; Harding AJ; Wong J
    J Clin Endocrinol Metab; 2017 Jan; 102(1):150-156. PubMed ID: 27797673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of change in haemoglobin A1c with adverse perinatal outcomes in women with pregestational diabetes.
    Kiefer MK; Finneran MM; Ware CA; Fareed N; Joseph J; Thung SF; Costantine MM; Landon MB; Gabbe SG; Venkatesh KK
    Diabet Med; 2022 Jul; 39(7):e14822. PubMed ID: 35261060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pregnancy outcomes among multi-ethnic women with different degrees of hyperglycaemia during pregnancy in an urban New Zealand population and their association with postnatal HbA1c uptake.
    Immanuel J; Eagleton C; Baker J; Simmons D
    Aust N Z J Obstet Gynaecol; 2021 Feb; 61(1):69-77. PubMed ID: 32880893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HbA1c at the time of testing for gestational diabetes identifies women at risk for pregnancy complications.
    Barbry F; Lemaitre M; Ternynck C; Wallet H; Cazaubiel M; Labreuche J; Subtil D; Vambergue A
    Diabetes Metab; 2022 May; 48(3):101313. PubMed ID: 34933118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediabetes and pregnancy: Early pregnancy HbA
    Jamieson EL; Spry EP; Kirke AB; Griffiths E; Porter C; Roxburgh C; Singleton S; Sterry K; Atkinson DN; Marley JV
    Diabetes Res Clin Pract; 2021 Jun; 176():108868. PubMed ID: 34023341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance of early pregnancy HbA
    Immanuel J; Simmons D; Desoye G; Corcoy R; Adelantado JM; Devlieger R; Lapolla A; Dalfra MG; Bertolotto A; Harreiter J; Wender-Ozegowska E; Zawiejska A; Dunne FP; Damm P; Mathiesen ER; Jensen DM; Andersen LLT; Hill DJ; Jelsma JGM; Snoek FJ; Scharnagl H; Galjaard S; Kautzky-Willer A; VAN Poppel MNM
    Diabetes Res Clin Pract; 2020 Oct; 168():108378. PubMed ID: 32828833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycated haemoglobin (HbA1c) in mid-pregnancy and perinatal outcomes.
    Carlsen EØ; Harmon Q; Magnus MC; Meltzer HM; Erlund I; Stene LC; Håberg SE; Wilcox AJ
    Int J Epidemiol; 2022 Jun; 51(3):759-768. PubMed ID: 34993542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycosylated haemoglobin as an indicator of diabetes control in pregnancy: A 10-year review of the relationship between HbA1c trends and delivery outcome in type I and type II diabetes.
    Finnegan C; Smyth S; Smith O; Dicker P; Breathnach FM
    Eur J Obstet Gynecol Reprod Biol; 2023 Feb; 281():36-40. PubMed ID: 36529065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Late-pregnancy dysglycemia in obese pregnancies after negative testing for gestational diabetes and risk of future childhood overweight: An interim analysis from a longitudinal mother-child cohort study.
    Gomes D; von Kries R; Delius M; Mansmann U; Nast M; Stubert M; Langhammer L; Haas NA; Netz H; Obermeier V; Kuhle S; Holdt LM; Teupser D; Hasbargen U; Roscher AA; Ensenauer R
    PLoS Med; 2018 Oct; 15(10):e1002681. PubMed ID: 30372451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is fasting plasma glucose in early pregnancy a better predictor of adverse obstetric outcomes than glycated haemoglobin?
    Mañé L; Flores-Le Roux JA; Pedro-Botet J; Gortazar L; Chillarón JJ; Llauradó G; Payà A; Benaiges D
    Eur J Obstet Gynecol Reprod Biol; 2019 Mar; 234():79-84. PubMed ID: 30665080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Women with a nondiagnostic 75 g glucose tolerance test but elevated HbA1c in pregnancy: an additional group of women with gestational diabetes.
    Rowan JA; Budden A; Sadler LC
    Aust N Z J Obstet Gynaecol; 2014 Apr; 54(2):177-80. PubMed ID: 24359339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics and outcomes of pregnant women with type 1 or type 2 diabetes: a 5-year national population-based cohort study.
    Murphy HR; Howgate C; O'Keefe J; Myers J; Morgan M; Coleman MA; Jolly M; Valabhji J; Scott EM; Knighton P; Young B; Lewis-Barned N;
    Lancet Diabetes Endocrinol; 2021 Mar; 9(3):153-164. PubMed ID: 33516295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. First-trimester glycaemic markers as predictors of gestational diabetes and its associated adverse outcomes: A prospective cohort study.
    D'Arcy RJ; Cooke IE; McKinley M; McCance DR; Graham UM
    Diabet Med; 2023 Feb; 40(2):e15019. PubMed ID: 36453695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is HbA1c in the first trimester associated with adverse outcomes among pregnant Asian Indian women without gestational diabetes?
    Punnose J; Malhotra RK; Sukhija K; Rijhwani RM; Choudhary N; Sharma A; Vij P; Bahl P
    J Diabetes Complications; 2022 May; 36(5):108187. PubMed ID: 35382965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.